Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

Protein ENGineering (PENG)

Active
DARPA-PS-26-129Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Defense Advanced Research Projects Agency (DARPA) is seeking innovative proposals under the Protein ENGineering (PENG) program, solicited through DARPA-PS-26-129, to develop a universal, software-defined platform for precise, programmable editing of endogenous proteins. The goal is to transform proteome engineering from fragmented, target-specific tools into an integrated system capable of directly recognizing, modifying, and rewriting proteins within complex biological environments using modular targeting, generalizable effector chemistries, and multiplexed control systems. Performers are expected to leverage novel splicing, ligation, and co-translational techniques to achieve these modifications in high-fidelity cellular models such as organoids, with progression from foundational validation to robust tissue-level demonstrations. The program is structured over a 42-month total period of performance, divided into an 18-month Base Phase 1, a 6-month Option Phase 1 for capability demonstration, and an 18-month Option Phase 2, spanning fiscal years 2027 through 2030. Performance will occur primarily at the contractor’s facility, with critical milestones requiring on-site demonstrations and DARPA team visits in Arlington, Virginia, where final evaluation and acceptance will take place. Proposals must adhere to strict formatting and documentation standards, including structured cost submissions using designated worksheets with sequentially numbered Reference Document IDs (e.g., EQ001, MAT010) for all equipment and materials over $5,000, supported by vendor quotes and detailed justifications. All cost estimates must comply with Federal Acquisition Regulation cost principles, and no deletion of template columns or cells is permitted. Key personnel—regardless of salary support—must be explicitly listed, and option periods must maintain continuity in document numbering with the base phase. While no explicit contract clauses, evaluation factors, or award methodology are provided, the solicitation emphasizes transparency, traceability, and compliance with Controlled Unclassified Information handling standards. Contractors must be prepared to submit proposals electronically by the October 19, 2026 deadline, with funding ceilings of up to $225,000 for Phase 1, $225,000 for Phase 2, and $160,000 for potential institutional innovation program participation, resulting in a maximum potential contract value of $610,000. No small business set-asides, socioeconomic certifications, or specific invoicing or payment office details are specified,

General Info

DARPA seeks programmable protein-editing platform for precise, modular, in vivo proteome control without genetic modifications.

Agency

Department Of Defense → Defense Advanced Research Projects AgcyView Agency

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)View NAICS

Place of Performance

VA

Set-Aside

NONE

Documents

(10)

DARPA-PS-26-129 Protein Engineering Cost Proposal Instructions and Volume II Template

DOCXcost-proposal-instructions

Attachment H Task Description Document

DOCXsow

Attachment_A_Abstract_Summary_Side.pptx

PPTX

Other Transaction Agreement for Prototype Development HR0011-XX-9-XXXX

DOCXother-transaction-agreement

DARPA-PS-26-129 Protein Engineering Proposal Instructions and Volume I Template

DOCXproposal-instructions

DARPA Cost Proposal Spreadsheet

XLSXcost-proposal-spreadsheet

DARPA-PS-26-129 Protein Engineering Abstract Instructions and Template

DOCXabstract-instructions-template

Schedule of Milestones and Payments Attachment I

XLSXschedule-of-milestones

DARPA-PS-26-129 Protein Engineering Program Solicitation

PDFps

Attachment_C_Proposal_Summary_Slide_Template.pptx

PPTX

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Advanced Research Projects Agcy
Contacts1 person available
OfficeARLINGTON, VA, 222032114, USA
Organization / Agency
Department Of Defense → Defense Advanced Research Projects Agcy
View Agency Profile
Office AddressARLINGTON, VA, 222032114, USA
Contacts
BAA Coordinator

Full Description

Show more
The Defense Advanced Research Projects Agency (DARPA) is soliciting innovative proposals for the development of a multifunctional, target-agnostic platform for precise, programmable editing of endogenous proteins. The goal of the Protein ENGineering (PENG) program is to transition proteome engineering from a collection of isolated, bespoke tools into a universal, software-defined discipline.

The PENG program will establish a comprehensive, integrated platform composed of modular targeting, generalizable effector chemistries, and multiplexed control systems. Rather than developing isolated, target-specific tools, performers will integrate novel splicing, ligation, and co-translational techniques to directly recognize, modify, and rewrite endogenous proteins within complex biological architectures. Performers may explore multiple technical paths, progressively advancing their approaches from foundational validation to robust demonstrations of efficacy. Ultimately, this integrated platform will be validated in high-fidelity cellular models (e.g., organoids), to provide an integrated proof-of-concept at the tissue level.

Similar Contracts

Same NAICS industry code

NAICS: 541714
New
Federal
Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA)
Solicitation # W911SR-26-R-HEAL
The Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA) is a continuous, open solicitation designed to establish a dynamic, pre-qualified network of partners to accelerate the development and fielding of next-generation medical defenses against CBRN threats. Operated by the Capability Program Executive for CBRN Defense (CPE CBRND) under the Department of Defense, this agreement functions as an Indefinite-Delivery Indefinite-Quantity (IDIQ)-like vehicle authorized under 10 U.S.C. §§4021, 4022, and 4023, exempting it from the Competition in Contracting Act of 1984. The program seeks innovative, threat-agnostic host-directed therapeutics that enhance physiological resilience by targeting critical systems such as neurological function, respiratory stability, immune response, hematologic and vascular integrity, and cellular stress and repair pathways. Complementary to this, the government also seeks broad-spectrum therapeutic candidates that can directly neutralize CBRN agents, with emphasis on agents possessing environmental stability, non-cold-chain storage capability, and simplified administration routes like oral, intranasal, or autoinjector formats suitable for immediate use in austere, far-forward operational environments. Interested parties, including MCM developers at any stage from Phase I through FDA licensure and supporting organizations such as CROs, CDMOs, and regulatory experts, must submit a white paper of no more than five pages detailing product mechanisms, efficacy data from validated animal models, regulatory status including IND history and clinical trial results, manufacturing capacity and scale-up plans, and company experience. Collaboration is mandatory, with applicants required to state willingness to team or partner within the PBA ecosystem. Participation requires SAM registration, and all award decisions are based on technical merit and strategic alignment with the program’s mission to build a layered, resilient, and sustainable medical defense portfolio, without fixed deadlines or competitive bidding. The agreement supports the development of dual-use medical solutions with potential applications in civilian critical care, emphasizing ruggedized formulations, clear labeling, durable packaging, and long-term stability to ensure readiness in the most challenging operational conditions. Technical and administrative inquiries should be directed to Hunter Robinson or Alexander Mayatte at the Aberdeen Proving Ground, Maryland office.
W6QK Acc-Apg

POSTED

3 days ago

DEADLINE

N/A
View Details
NAICS: 541714
New
SBIR / STTR
Universal Cell Culture Platform for Rapid Establishment of Species-Agnostic Cell Lines and Autonomous Culture Operations
Solicitation # DPA26BZ05-DV020
Establishing cell culture systems for non-model vertebrate and invertebrate species remains a major bottleneck in biotechnology, severely limiting progress in gene-drive research, biocontrol development, and species-specific biomanufacturing. Current methods require years of labor-intensive, operator-dependent optimization tailored to each species, with protocols that rarely transfer between labs and lack reproducibility. This contract seeks an integrated platform that eliminates these inefficiencies by enabling rapid, universal derivation of stable cell lines from any species—regardless of taxonomic distance from established models—through species-agnostic biological techniques. These methods must support primary cell isolation, induced pluripotent stem cell reprogramming, and long-term maintenance using broadly applicable media, substrates, and reprogramming strategies that do not rely on species-specific reagents or markers, while also enabling validation of pluripotency, genomic stability, and differentiation potential in the absence of conventional reference tools. To accelerate this process, the platform must pair these biological innovations with fully autonomous, closed-loop automation capable of conducting high-throughput, parallelized experiments with minimal human intervention. The system must independently control environmental parameters at the vessel or well level, perform routine and complex cell culture operations—including feeding, passaging, imaging, and sampling—and use integrated machine-learning-driven analysis to interpret cellular health and morphology, then iteratively propose and execute new experimental conditions. This automation must generate fully digitized, transferable protocols that are reproducible across instruments and locations, compressing years of development into weeks or months. Where applicable, the platform must further support gene-drive and genetic-biocontrol research by providing validated cellular testbeds—including germline or developmentally relevant cell types—that enable in vitro measurement of homing efficiency, off-target activity, stability, and fitness costs, along with molecular containment and safety evaluation strategies. All work under the gene-drive component must remain strictly in vitro, with no environmental release or creation of gene-drive-competent organisms permitted, and must incorporate responsible research practices, biosafety protocols, and institutional oversight. The ultimate goal is a unified system that seamlessly links universal cell culture methods with automated optimization and targeted genetic validation to rapidly enable biological capabilities across the full spectrum of understudied species.
Defense Advanced Research Projects Agency

POSTED

3 days ago

DEADLINE

in 18 days
View Details
NAICS: 541714
New
Federal
Evaluation of a Lead NNMT Inhibitor in Humanized M
Solicitation # 75N98026Q00941
The National Institutes of Health, Office of the Director, intends to award a non-competitive, firm-fixed price contract to GemPharmatech LLC for the evaluation of a lead NNMT inhibitor using a humanized nicotinamide N-methyltransferase mouse model, a model uniquely developed and maintained by GemPharmatech under prior NIH funding. This acquisition is conducted under streamlined commercial item procedures and is not expected to exceed the simplified acquisition threshold, with authority derived from FAR 12.603 and 41 U.S.C. 1901, and justified under the sole source exception for unique capabilities, as GemPharmatech is the only entity with the cryopreserved sperm and breeding resources necessary to regenerate the required mouse colony essential for generating scientifically relevant efficacy data due to the inhibitor's species-specific activity. The solicitation number is 75N98026Q00941, issued as a combined synopsis and solicitation without competitive procedures, and responses are due by August 19, 2026. The work falls under NAICS code 541714 for Research and Development in Biotechnology with a small business size standard of 1,000 employees, and this requirement is not set aside for small business. The contract will be managed by the NIH Office of Acquisitions based in Bethesda, Maryland, with the primary point of contact being Johnstona C. Johnston, reachable via email. All provisions and clauses follow those in effect through the Federal Acquisition Circular dated August 4, 2026, and the notice serves as the complete and only solicitation document; no additional written solicitation will be issued. The performance location is not specified beyond the federal agency's administrative details.
National Institutes Of Health Olao

POSTED

4 days ago

DEADLINE

in 11 days
View Details
NAICS: 541714
New
Federal
Yeast Two-Hybrid (Y2H) Screening Service
Solicitation # 1232SA26Q1181
The U.S. Department of Agriculture’s Agricultural Research Service is soliciting quotations for Yeast Two-Hybrid (Y2H) Screening Services under solicitation number 1232SA26Q1181, issued as a combined synopsis and solicitation in accordance with FAR Part 12 for commercial items. This acquisition is exclusively reserved for small business concerns, with the North American Industry Classification System code 541714 for Research and Development in Biotechnology and a size standard of 1,000 employees, making it a total small business set-aside. Only responsible small business sources may submit quotations, which will be evaluated without the issuance of a separate written solicitation. The quote submission deadline is August 28, 2026, at 22:00 Eastern Time, with the solicitation publicly posted on August 4, 2026, and responses due to the USDA ARS office located in Beltsville, Maryland. The performance of the Y2H screening services is required to take place in Ithaca, New York, 14853. The primary point of contact for inquiries is Kerrie Hodges, reachable via email at kerrie.hodges@usda.gov. The contract is being procured by the USDA ARS Affiliated Programs and Development office and is intended to support research activities for the Robert W. Holley Center for Agriculture and Health. Interested parties must submit their quotations through the SAM.gov platform using the provided UI link, and all responses must comply with the commercial item procurement procedures outlined in FAR Part 12. No further documentation or separate solicitation documents will be issued.
USDA Ars Afm Apd

POSTED

4 days ago

DEADLINE

in 21 days
View Details
NAICS: 541714
New
Federal
AN11--36C25226R0084 - TBI research with Arraystar Inc FY2026
Solicitation # 36C25226R0084
The Department of Veterans Affairs is seeking information from potential vendors to support a sole source procurement for Methylated and hydroxymethylated DNA immunoprecipitation sequencing (MeDIP-seq and hMeDIP-seq) services under solicitation number 36C25226R0084. This effort is part of a TBI research project at the William S Middleton VA Medical Center in Madison, Wisconsin, aimed at understanding epigenetic changes—specifically the roles of 5-methylcytosine and 5-hydroxymethylcytosine—in secondary brain damage following trauma. The contract requires comprehensive sequencing and data analysis of mouse brain tissue samples from adult and aged males and females to identify sex- and age-specific patterns. The work must be performed using the same tissue samples for both MeDIP and hMeDIP to minimize variability and ensure reliable comparative results. The vendor will deliver raw sequencing data in Fastq format, quality control reports, analytical summaries, and final project reports in Excel, PDF, and PNG formats within 56 to 70 days of contract start. Submission of capability statements is required by August 10, 2026, via email only, with no phone inquiries accepted, and must include customer references and technical proof of capability. This is not a solicitation or request for proposals but a sources sought notice to justify a sole source award under 41 U.S.C. 1901, as the VA believes only one vendor can meet the highly specialized scientific requirements. The principal investigator will evaluate all submissions due to the technical nature of the research and will determine vendor suitability. The contract, if awarded, will be a firm fixed price agreement for one year, with no option periods, running from August 10, 2026, to August 9, 2027. All deliverables must be transmitted via USB drive, as the research laboratory operates in an affiliate space disconnected from the VA network. Responses must be emailed to Tiarrah Turner at the VA Great Lakes Acquisition Center in Milwaukee, Wisconsin, with attachments not exceeding 8 MB each. The government retains full discretion to proceed with sole source negotiation regardless of responses received. No federal funds are allocated under the Recovery Act for this procurement.
252-NETWORK Contract Office 12 (36C252)

POSTED

5 days ago

DEADLINE

in 2 days
View Details
NAICS: 541714
New
Grant
Emerging Infections Network - Research for Preventing, Detecting, and Managing Travel-associated Infectious Diseases
Solicitation # RFA-CK-26-035
The Centers for Disease Control and Prevention, under the Department of Health and Human Services, is soliciting applications through RFA-CK-26-035 to establish a dual-component surveillance network aimed at detecting, preventing, and managing infectious diseases among international travelers. The initiative targets two key environments: clinic-based sentinel sites serving travelers and wastewater-based monitoring at major international transportation hubs, including airports in Addis Ababa, Nairobi, Istanbul, Bangkok, Seoul, and São Paulo. The goal is to enhance early outbreak detection, refine diagnostic and treatment strategies, improve genomic surveillance, and strengthen global health security by generating timely, actionable public health data. Applications may be submitted for Component A, Component B, or both, with the understanding that if a proposal for both components is top-ranked, only Component B will be funded. The program is structured as a cooperative agreement with a five-year performance period beginning September 1, 2027, and an estimated total funding range of $8.75 million to $30 million across both components, with annual funding tiers specified per component. Applicants must adhere to strict submission protocols using the NIH SF-424 (R&R) application package, including a 12-page research strategy per component and a 1-page specific aims section, with no more than 10 PDF attachments allowed in the appendix. Critical requirements include registration in SAM.gov for a Unique Entity ID, eRA Commons registration for all key personnel, IRB approval for human subjects research, OMB-PRA clearance for data collection, and submission of a Bona Fide Agent document, an indirect cost agreement, and a report on proposal overlap if applicable. The CDC will maintain substantial programmatic involvement, requiring prior approval for publications and active collaboration in project execution. Evaluation is based on five scientific merit criteria—Significance, Investigators, Innovation, Approach, and Environment—scored on a 1-to-9 scale, with the final award decision guided by scientific merit, program relevance, portfolio balance, and geographic distribution, not cost. Payment is administered under federal grant rules, with indirect costs capped at 15% using the de minimis rate unless an approved rate is provided. Final reports are due 120 days after project completion, and all data must be shared via the global GLOWACON platform under standardized protocols for wastewater sampling, metagenomic sequencing, and bioinformatics analysis.
Centers For Disease Control And Prevention

POSTED

5 days ago

DEADLINE

in 3 months
View Details
NAICS: 541714
Federal
Presolicitation Notice - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response
Solicitation # 75A50126R00001_RFP_PreSolNotice_NPIVS-2027
The U.S. Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority (BARDA), is seeking qualified contractors to support the ongoing Vaccine Medical Countermeasures for Pandemic Influenza Preparedness and Response Program. Contractors must be capable of furnishing all necessary services, personnel, equipment, materials, and U.S.-based facilities to produce vaccines, antigens, and adjuvants for pandemic influenza and other viruses with pandemic potential. To be eligible, offerors must either hold an active U.S. influenza vaccine license from the FDA or have submitted a Biologics License Application for a seasonal or pandemic influenza vaccine. The program demands the generation and submission of comprehensive regulatory data—including analytical, nonclinical, clinical, and chemistry, manufacturing, and controls (CMC) information—to the FDA to enable rapid decision-making and maintain manufacturing readiness during interpandemic periods. The anticipated contract is an indefinite delivery, indefinite quantity (IDIQ) vehicle with a base performance period of 60 months and the potential to extend up to 120 months if all option periods are exercised, combining both cost-reimbursement and firm-fixed-price task orders. Performance is expected to occur primarily within the United States, with the place of performance designated as Washington, D.C., and the contracting office located at 400 7th Street SW. Proposals must be submitted electronically via SAM.gov by the deadline of August 15, 2026, and are subject to evaluation based on mandatory qualification requirements, with full evaluation factors and source selection criteria expected to be detailed in the forthcoming Request for Proposals. The solicitation number is 75A50126R00001, and the NAICS code is 541714 for research and development in biotechnology. The primary point of contact for inquiries is Laura Saddison, BARDA Contracting Officer, reachable at Laura.Saddison@hhs.gov. No set-aside is planned, and full and open competition is anticipated. While packaging, marking, inspection procedures, and specific invoicing methods are not defined in this presolicitation, contractors should prepare to comply with FDA regulatory standards and anticipate the use of federal systems such as WAWF for payment processing. No contracting officer’s representative or technical representative has been designated yet, and all certifications and representations will be required upon formal proposal submission.
Barda - Aspr / Daappo / Barda Dcma

POSTED

8 days ago

DEADLINE

in 8 days
View Details
NAICS: 541714
Federal
Convergence Special Notice
Solicitation # DARPA-SN-26-108
The Convergence program seeks to revolutionize environmental monitoring for defense operations by integrating synthetic biology and engineering to create advanced microbial biosensors capable of detecting chemical and pharmaceutical hazards in austere environments. Leveraging non-pathogenic microbial consortia built on well-characterized, safe host organisms like E. coli, the initiative focuses on developing modular biological systems that translate environmental inputs into standardized, detectable outputs. The program’s development follows a structured four-tiered approach, progressing from component-level design and integrated payload engineering to full system integration within a microbial chassis, ultimately aiming for a deployable platform ready for U.S. and international regulatory certification. This systematic progression ensures that each layer of functionality is rigorously validated before scaling to operational readiness. To enable safe, responsible, and globally viable deployment, the program includes a dedicated ecosystem of testing and collaboration. Performance and safety validation will first occur within the United States before exploring international adoption, with two specialized working groups guiding the process: one focused on navigating socio-political landscapes and local environmental regulations, and another managing cooperative use cases and deployment protocols with global allies. Administered by DARPA, the solicitation under number DARPA-SN-26-108 invites multidisciplinary teams in synthetic biology, environmental science, and engineering to contribute to this initiative, with responses due by August 6, 2026. The program is headquartered in Arlington, Virginia, and is led by Mark Salvador, with the goal of delivering a scalable, secure, and globally interoperable biosensor platform for the protection of military personnel.
Defense Advanced Research Projects Agcy

POSTED

9 days ago

DEADLINE

in 4 days
View Details
NAICS: 541714
Federal
Multiscale Reasoning For Human Physiology RFI
Solicitation # DARPA-SN-26-100
The Defense Advanced Research Projects Agency’s Biological Technologies Office is seeking input on cutting-edge technologies that enable multiscale reasoning across human physiology through this Request for Information, identified as DARPA-SN-26-100. The focus is on emerging tools including artificial intelligence systems, foundation models, computational frameworks, and datasets capable of integrating biological, physiological, and clinical data across multiple scales—from molecular and cellular levels to organ systems and whole-body responses. The goal is to advance the ability to model, predict, and interpret complex human physiological behavior using AI and data-driven approaches, with interest in non-traditional performers and innovative solutions from industry, academia, government labs, and healthcare organizations. Responses are due by August 10, 2026, and the solicitation falls under NAICS code 541714 for research and development in the physical, engineering, and life sciences. All submissions should be directed to Dr. Roozbeh Jafari, Program Manager at DARPA/BTO, via bioreasoning@darpa.mil. The office is located in Arlington, Virginia, and while no specific place of performance is defined, selected technologies may be developed and evaluated through future DARPA programs. This RFI does not constitute a solicitation for proposals or obligations but aims to inform upcoming funding opportunities in the field of physiological modeling and AI-driven biological insight.
Defense Advanced Research Projects Agcy

POSTED

9 days ago

DEADLINE

in 13 days
View Details
NAICS: 541714
Federal
Trusted Partner Program Coming Soon
Solicitation # W911NF26RA009
The U.S. Army, through the Army Research Office and the Office of Contracting at Research Triangle Park, North Carolina, is issuing a presolicitation for the Trusted Partner Program, a multiple-award IDIQ contract aimed at establishing a cadre of trusted academic partners—including institutions of higher education and their affiliated entities—to conduct rapid, sensitive basic and applied scientific research in support of national defense priorities. The solicitation, numbered W911NF26RA009, targets research in Scaled Directed Energy and Scaled Hypersonics, requiring multidisciplinary expertise across physics, electronics, chemistry, materials science, information sciences, and biology, with an emphasis on integrating these fields to address complex Army needs. The base performance period is five years, beginning September 2026, with an optional five-year extension, bringing the total potential contract value to $400 million, with individual task orders to be issued under cost-plus-fixed-fee or firm-fixed-price arrangements. Offerors must submit proposals in five separate volumes, each as a searchable PDF, along with a supplemental unclassified video pitch between three and seven minutes in length, formatted in MPEG-4 at 1080p resolution. Proposals are due by 4:00 PM Eastern Time on July 15, 2026, and must be emailed to the designated point of contact. Evaluation will be conducted based on five factors, ranked in order of importance: Technical (most important), Management, Past Performance, Small Business, and Cost & Business Structure (least important non-cost factor). No numerical weights are assigned, and the award will be made using a trade-off process emphasizing superior technical merit over price, with the expectation that all non-cost factors combined carry significantly greater weight than cost. The Technical factor includes equally weighted subfactors centered on expertise in six core disciplines and six critical interdisciplinary projects, assessed using adjectival ratings from BLUE (outstanding, low risk) to RED (unacceptable, unawardable). Compliance with regulatory requirements is strict: contractors must maintain active UEI and CAGE codes in SAM, adhere to cybersecurity maturity model certification requirements, and submit all deliverables in accordance with Department of Transportation packaging standards and marking requirements that include contract number, project title, and sensitive data classification. Travel is highly regulated, requiring prior COR approval and adherence to JTR per diem limits; OCONUS travel necessitates SPOT registration and a Letter of Authorization. Organizational conflicts of interest will be rigorously assessed, and all
W6QK Acc-Apg Durham

POSTED

10 days ago

DEADLINE

N/A
View Details

More opportunities from Department Of Defense → Defense Advanced Research Projects Agcy

Same awarding agency

NAICS: 423490
New
Federal
Equipment Procurement & Technical SupplyThe contract pertains to the procurement of specialized research and prototyping equipment intended for use in advanced defense-related technical initiatives, with strict adherence to Federal Acquisition Regulation (FAR) 45 requirements governing government-owned property. All acquired equipment must maintain full traceability throughout its lifecycle, including documentation of acquisition, installation, maintenance, and disposition, ensuring accountability and compliance with federal property standards. The equipment is critical to supporting high-priority research activities under the purview of the Defense Advanced Research Projects Agency and must be delivered in accordance with technical specifications that meet operational and security mandates. This subcontract opportunity was posted on August 7, 2026, with a response deadline of October 19, 2026, and falls under NAICS code 423490 for miscellaneous durable goods merchant wholesalers. The place of performance and agency office details are unspecified, but the work is directly tied to Department of Defense activities. Proposals must demonstrate proven capability in supplying high-precision research instrumentation with documented compliance processes, including inventory control, asset tagging, and audit-ready records. The procurement emphasizes technical excellence, regulatory rigor, and the ability to integrate equipment into existing government infrastructure without compromising oversight or security protocols.
Other Professional Equipment and Supplies Merchant Wholesalers

POSTED

about 18 hours ago

DEADLINE

in 2 months
View Details
NAICS: 485510
New
Federal
Travel & Field Demonstration SupportThe contract seeks a subcontractor to provide comprehensive logistics and travel coordination services for on-site demonstrations and site visits to contractor facilities, encompassing both domestic travel and the movement of technical teams. This effort supports field operations tied to Defense Advanced Research Projects Agency initiatives, requiring precise planning and execution for timely, secure, and efficient travel arrangements that align with federal and contractor protocols. All activities are centered around enabling critical demonstrations that may involve sensitive technologies or facilities, demanding strict adherence to operational security and scheduling requirements. The opportunity is posted under NAICS code 485510, which classifies it as transit and ground passenger transportation, reflecting the specialized nature of coordinated travel support. The contract is structured as a subcontract, indicating it is part of a larger prime contract ecosystem within the Department of Defense. The response deadline is October 19, 2026, with the solicitation made public in August 2026, leaving ample time for qualified entities to prepare detailed proposals. While the place of performance and agency office details are unspecified, the scope implies national coverage across multiple contractor locations, requiring vendors to have proven capabilities in managing complex, multi-jurisdictional travel logistics under federal guidelines.
Charter Bus Industry

POSTED

about 18 hours ago

DEADLINE

in 2 months
View Details
NAICS: 541715
New
Federal
Research & Development – Advanced Technology PrototypingThis contract pertains to advanced technology prototyping under a DARPA-managed research and development initiative, focusing on technical development that integrates systems engineering, algorithm design, and hardware-software co-design. It is structured as a subcontract with a multi-phase execution approach, requiring innovative solutions that push the boundaries of current capabilities in defense-related technologies. The work will involve iterative prototyping and demonstration of novel systems, with each phase building on the outcomes of the prior one to validate technical feasibility and operational relevance. The opportunity is open for responses until October 19, 2026, and is classified under NAICS code 541715 for research and development in the physical, engineering, and life sciences. Performance is expected to be conducted under the auspices of the Department of Defense, though specific location details are not defined. The contract is part of a broader effort to accelerate the transition of cutting-edge research into practical prototypes, with an emphasis on rapid development cycles and cross-disciplinary collaboration. Respondents must demonstrate expertise in high-risk, high-reward technology development aligned with DARPA’s strategic goals, and proposals are expected to address scalability, manufacturability, and potential for operational deployment.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

about 18 hours ago

DEADLINE

in 2 months
View Details
NAICS: 541512
New
Federal
Data Integration & Multimodal Analytics PlatformThe contract seeks the development of a software platform designed to integrate and analyze diverse multimodal data streams including molecular, imaging, electrophysiological, and behavioral data to model and predict outcomes related to neuroplasticity. This initiative aims to advance the understanding of how neural systems adapt and reorganize by creating unified analytical tools capable of correlating complex biological and functional signals across multiple domains. The platform must support scalable data processing, robust algorithmic frameworks for pattern recognition, and predictive modeling capabilities that can translate integrated datasets into actionable neuroscientific insights. This is a subcontract under the Department of Defense, specifically managed by the Defense Advanced Research Projects Agency, with a NAICS code of 541512 indicating it falls under custom computer programming services. The opportunity was posted on August 6, 2026, with a deadline for responses on August 14, 2026. Performance location details are not specified, and no set-aside provisions or point of contact information are provided. The work is intended to support advanced defense-related neuroscience applications requiring high-fidelity data fusion and predictive analytics, with no restrictions on bidder eligibility indicated beyond standard subcontracting requirements.
Computer Systems Design Services

POSTED

1 day ago

DEADLINE

in 6 days
View Details
NAICS: 541715
New
Federal
Synthetic Biology for Neural Circuit RepairThe contract seeks to advance synthetic biology for the repair of neural circuits by engineering biological systems capable of detecting neural damage and initiating regenerative responses, with a focus on gene therapies and modified cellular platforms. The work involves designing and constructing novel biological components that can sense injury signals in the nervous system and respond with targeted therapeutic actions, aiming to restore function in damaged neural networks. This effort is part of a broader initiative under the Department of Defense to pioneer next-generation medical technologies for battlefield and clinical applications. The opportunity is designated as a subcontract with a NAICS code of 541715, indicating it falls under research and development in the life sciences. It was posted on August 6, 2026, with a response deadline of August 14, 2026, leaving a narrow window for qualified entities to submit proposals. The contracting agency is the Defense Advanced Research Projects Agency, suggesting the project is high-priority and tied to national defense health objectives. There is no set-aside classification specified, and detailed contact or location information is not provided, indicating a centralized and potentially confidential procurement process handled through the SAM.gov portal.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

1 day ago

DEADLINE

in 6 days
View Details